Inventor · disambiguated record
Randolph J. Noelle
Also filed as: NOELLE RANDOLPH · NOELLE RANDOLPH J
66 granted patents·37 pending applications·1,312 citations·filing 1993–2024
99Inventor score
Files withDARTMOUTH COLLEGE43IO THERAPEUTICS INC15NOELLE RANDOLPH J14KING S COLLEGE LONDON11BRISTOL MYERS SQUIBB CO3
Top patents by PatentIndex Score
103 records- 0199US11180557B2Vista modulators for diagnosis and treatment of cancerKING S COLLEGE LONDON·Filed 2017·Granted Nov 23, 2021·49 cites·10 claims
- 0298US9890215B2Vista modulators for diagnosis and treatment of cancerKING S COLLEGE LONDON·Filed 2014·Granted Feb 13, 2018·26 cites·8 claims
- 0398US7387271B2Immunostimulatory combinations3M INNOVATIVE PROPERTIES CO·Filed 2003·Granted Jun 17, 2008·172 cites·77 claims
- 0497US10035857B2Regulatory T cell mediator proteins and uses thereofDARTMOUTH COLLEGE·Filed 2015·Granted Jul 31, 2018·19 cites·7 claims
- 0597US9631018B2Vista regulatory T cell mediator protein, vista binding agents and use thereofNOELLE RANDOLPH J·Filed 2011·Granted Apr 25, 2017·41 cites·12 claims
- 0697US9381244B2VISTA modulators for diagnosis and treatment of cancerDARTMOUTH COLLEGE·Filed 2013·Granted Jul 5, 2016·40 cites·14 claims
- 0797US9217035B2Regulatory T cell mediator proteins and uses thereofNOELLE RANDOLPH J·Filed 2013·Granted Dec 22, 2015·31 cites·15 claims
- 0897US9028826B2Methods of immune therapy with anti-CD154 antibodies having impaired FcR binding and/or complement binding propertiesDARTMOUTH COLLEGE·Filed 2013·Granted May 12, 2015·27 cites·13 claims
- 0997US8231872B2Regulatory T cell mediator proteins and uses thereofNOELLE RANDOLPH J·Filed 2010·Granted Jul 31, 2012·35 cites·7 claims
- 1097US7993659B2TLR9 agonist and CD40 agonist immunostimulatory combinations3M INNOVATIVE PROPERTIES CO·Filed 2008·Granted Aug 9, 2011·64 cites·51 claims
- 1196US8501915B2Regulatory T cell mediator proteins and uses thereofNOELLE RANDOLPH J·Filed 2012·Granted Aug 6, 2013·25 cites·8 claims
- 1296US8236304B2Use of PD-L3 proteins and PD-L3 specific antibodies or antibody fragments to regulate CD4+ and CD8+ T cell immunityNOELLE RANDOLPH J·Filed 2006·Granted Aug 7, 2012·48 cites·4 claims
- 1395US11529416B2Vista modulators for diagnosis and treatment of cancerKING S COLLEGE LONDON·Filed 2019·Granted Dec 20, 2022·5 cites·8 claims
- 1495US11414490B2Regulatory T cell mediator proteins and uses thereofDARTMOUTH COLLEGE·Filed 2018·Granted Aug 16, 2022·6 cites·9 claims
- 1595US8465740B2Regulatory T cell mediator proteins and uses thereofNOELLE RANDOLPH J·Filed 2011·Granted Jun 18, 2013·29 cites·6 claims
- 1695US5747037AAnti-GP39 antibodiesBRISTOL MYERS SQUIBB CO·Filed 1995·Granted May 5, 1998·97 cites·8 claims
- 1794US10933115B2VISTA antagonist and methods of useKING S COLLEGE LONDON·Filed 2015·Granted Mar 2, 2021·10 cites·6 claims
- 1894US9321833B2Methods of therapy with anti-CD154 antibodies having impaired FcR binding and/or complement binding propertiesDARTMOUTH COLLEGE·Filed 2012·Granted Apr 26, 2016·9 cites·14 claims
- 1994US5876718AMethods of inducing T cell non-responsiveness to transplanted tissues and of treating graft-versus-host-disease with anti-gp39 antibodiesDARTMOUTH COLLEGE·Filed 1998·Granted Mar 2, 1999·86 cites·8 claims
- 2093US10781254B2VISTA regulatory T cell mediator protein, VISTA binding agents and use thereofDARTMOUTH COLLEGE·Filed 2017·Granted Sep 22, 2020·5 cites·4 claims
- 2192US10105426B2Immunostimulatory combinationsDARTMOUTH COLLEGE·Filed 2015·Granted Oct 23, 2018·8 cites·8 claims
- 2292US9161976B2Immunotherapy comprising TLR9 ligand and CD40 ligandDARTMOUTH COLLEGE·Filed 2012·Granted Oct 20, 2015·13 cites·19 claims
- 2392US8852597B2Anti-CD154 antibodies having impaired FcR binding and/or complement binding propertiesNOELLE RANDOLPH J·Filed 2012·Granted Oct 7, 2014·19 cites·10 claims
- 2492US8329197B2Ex vivo uses of immunostimulatory combinationsNOELLE RANDOLPH J·Filed 2010·Granted Dec 11, 2012·15 cites·12 claims
- 2591US10745467B2VISTA-Ig for treatment of autoimmune, allergic and inflammatory disordersDARTMOUTH COLLEGE·Filed 2013·Granted Aug 18, 2020·9 cites·9 claims
- 2690US11752189B2Vista antagonist and methods of useDARTMOUTH COLLEGE·Filed 2019·Granted Sep 12, 2023·3 cites·17 claims
- 2789US11166927B2Autoimmune disorder treatment using RXR agonistsIO THERAPEUTICS INC·Filed 2020·Granted Nov 9, 2021·1 cites·21 claims
- 2889US9758587B2Methods of immune therapy with anti-CD154 antibodies having impaired FcR binding and/or complement binding propertiesDARTMOUTH COLLEGE·Filed 2015·Granted Sep 12, 2017·3 cites·14 claims
- 2987US10822423B2Methods of immune therapy with anti-CD154 antibodies having Fc modificationsDARTMOUTH COLLEGE·Filed 2017·Granted Nov 3, 2020·2 cites·8 claims
- 3086US10201512B2Autoimmune disorder treatment using RXR agonistsIO THERAPEUTICS INC·Filed 2017·Granted Feb 12, 2019·2 cites·10 claims
- 3186US8415154B2Compositions and methods for producing adaptive regulatory T cellsNOELLE RANDOLPH J·Filed 2008·Granted Apr 9, 2013·5 cites·2 claims
- 3286US6376459B1Inhibiting B cell activation with soluble CD40 or fusion proteins thereofBRISTOL MYERS SQUIBB CO·Filed 1993·Granted Apr 23, 2002·58 cites·12 claims
- 3386US5869049AMethods of inducing T cell unresponsiveness to bone marrow with gp39 antagonistsDARTMOUTH COLLEGE·Filed 1994·Granted Feb 9, 1999·77 cites·27 claims
- 3485US6312692B1Method of treating graft-versus-host disease with anti-GP39 antibodies and bone marrow cellsDARTMOUTH COLLEGE·Filed 1998·Granted Nov 6, 2001·46 cites·12 claims
- 3585US5683693AMethod for inducing T cell unresponsiveness to a tissue or organ graft with anti-CD40 ligand antibody or soluble CD40DARTMOUTH COLLEGE·Filed 1994·Granted Nov 4, 1997·52 cites·34 claims
- 3684US5833987ATreatment of T cell mediated autoimmune disordersDARTMOUTH COLLEGE·Filed 1995·Granted Nov 10, 1998·51 cites·2 claims
- 3784US2023406945A1ANTI-CD154 ANTIBODIES HAVING IMPAIRED FcR BINDING AND/OR COMPLEMENT BINDING PROPERTIES AND USE IN THERAPYDARTMOUTH COLLEGE·Filed 2023·Application pending·0 cites
- 3883US11793781B2Autoimmune disorder treatment using RXR agonistsIO THERAPEUTICS INC·Filed 2022·Granted Oct 24, 2023·0 cites·23 claims
- 3983US11576881B2Autoimmune disorder treatment using RXR agonistsIO THERAPEUTICS INC·Filed 2021·Granted Feb 14, 2023·0 cites·21 claims
- 4082US7476385B2Methods of inhibiting IgE responses to thymus-dependent antigens with the anti-gp39 antibody MR1TRUSTEES OF DARTHMOUTH COLLEGE·Filed 2005·Granted Jan 13, 2009·6 cites·8 claims
- 4180US12383521B2Treatment of diseases by concurrently eliciting remyelination effects and immunomodulatory effects using selective RXR agonistsIO THERAPEUTICS INC·Filed 2022·Granted Aug 12, 2025·0 cites·21 claims
- 4280US2023338525A1Vista modulators for diagnosis and treatment of cancerKING S COLLEGE LONDON·Filed 2022·Application pending·0 cites
- 4379US2022259310A1Anti-human vista antibodies and use thereofIMMUNEXT INC·Filed 2022·Application pending·0 cites
- 4479US2024228609A9Vista regulatory t cell mediator protein, vista binding agents and use thereofDARTMOUTH COLLEGE·Filed 2023·Application pending·0 cites
- 4578US11246845B2Autoimmune disorder treatment using RXR agonistsIO THERAPEUTICS INC·Filed 2020·Granted Feb 15, 2022·0 cites·19 claims
- 4678US10945976B2Autoimmune disorder treatment using RXR agonistsIO THERAPEUTICS INC·Filed 2018·Granted Mar 16, 2021·0 cites·19 claims
- 4777US10034845B2Autoimmune disorder treatment using RXR agonistsIO THERAPEUTICS INC·Filed 2015·Granted Jul 31, 2018·1 cites·9 claims
- 4877US2024158507A1VISTA Antagonist and Methods of UseDARTMOUTH COLLEGE·Filed 2023·Application pending·0 cites
- 4976US11613583B2Nucleic acids encoding an anti-CD154 antibody comprising E269R and K322A mutationsDARTMOUTH COLLEGE·Filed 2020·Granted Mar 28, 2023·0 cites·11 claims
- 5076US10695307B2Autoimmune disorder treatment using RXR agonistsIO THERAPEUTICS INC·Filed 2018·Granted Jun 30, 2020·0 cites·16 claims
Showing the top 50 of 103 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →